Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Has results
×
soluble LAG-3 protein, human
×
Clear all
Filters
3
NCT03625323
2024-12-18
TACTI-002
Immutep S.A.S.
Phase 2
Completed
187 enrolled
13 charts